October 23, 2024
7 min read
The impact of CKD: Why better, accessible treatments and diagnostics are crucial
Supporting National Kidney Week 2024
UBC Insights
Insights from
UBC's Expert Voices
Featured Updates
Blog
June 11, 2025
4 min read
Linking real-world data with commercial patient access programs: A strategy for enhanced insights into factors that impact patient access and adherence to therapy
UBC’s approach to real-world data tokenization and linkage enhances study results with longitudinal observation of various participant health outcomes during the pre-and post-trial period.
Blog
April 28, 2025
8 min read
Longitudinal Real-World Data: How to Gain Deeper Insights Into Your Clinical Studies
Linking longitudinal real-world data (RWD) to clinical study data offers deeper insights for drug developers. Contextualize study outcomes, extend data collection after the study ends, close the efficacy-effectiveness gap, and identify post-market patterns.
Blog
April 15, 2025
7 min read
Evolving PV Landscape: Artificial Intelligence and Advanced Gene Therapy
UBC Pharmacovigilance experts, Dobrochna Dolicka, Christopher Henry, Alix Garcia and Irene Navarro presented at DIA Europe 2025 on how AI can be used to streamline pharmacovigilance activities and how harmonization of guidelines can be enhanced in order to define a specific framework for gene therapy.
Posts by Date
Blog
Blog
October 14, 2024
1 min read
Podcast | Boosting Patient Adherence: The Power of Clinical Support Programs
UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.
Blog
October 14, 2024
5 min read
The Importance of Good Collaboration between Different Vendors to Ensure Compliance with Global and Local Regulations
In the realm of pharmaceuticals, regulatory compliance is paramount to ensure patient safety. With the complex environment of safety reporting, several vendors may be involved at global and local levels for performing submission activities to health authorities, ethics committees and investigators. Director of UBC Global Case Processing, Myrto Ioannidi and UBC Team Manager, Esther Aparicio review […]
Blog
October 1, 2024
4 min read
DCTs: Beyond Hype and To a Hybrid Future
Clinical trials provide a limited view of patient experience but this can be expanded through tokenization to link pre- and post-trial data.
Blog
September 16, 2024
5 min read
The Importance of Choosing the Right Pharmacovigilance Partner and Safety Physician
For most pharmaceutical companies, hiring a PV team will help alleviate some of the work of the existing internal team.
Blog
August 29, 2024
6 min read
Putting the ‘Patient’ Back in Patient Services
Putting the patient back in patient services means we do more, go deeper, and customize offerings.
Blog
August 26, 2024
6 min read
EMA/HMA Revised Guidance on Risk Minimization Measures
UBC is the leading provider of evidence development solutions with expertise in uniting evidence and access.
Blog
August 16, 2024
4 min read
The Importance of Patient Choice
Providing the patient with choice throughout their journey empowers them to take an active role in therapy initiation and persistence.
Blog
August 5, 2024
6 min read
Navigating Launch Readiness with FDA Negotiations
REMS readiness is a key component for certain drugs launch plans - are you on top of approval timelines and milestones and IT build needs?
Previous
